At 38 weeks gestation with severe asymmetric fetal growth restriction (abdominal circumference 2.3th percentile, estimated fetal weight 20th percentile), a normal amniotic fluid index of 8.23 cm, and a ductus arteriosus systolic/diastolic ratio of 2.11, should delivery be induced with continuous intrapartum fetal monitoring if the umbilical‑artery Doppler study is normal, or performed by cesarean section if the umbilical‑artery Doppler shows absent or reversed end‑diastolic flow?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Severe Asymmetric FGR at 38 Weeks with Normal Umbilical Artery Doppler

At 38 weeks gestation with severe asymmetric fetal growth restriction (abdominal circumference 2.3rd percentile, estimated fetal weight 20th percentile), normal amniotic fluid index (8.23 cm), and normal umbilical artery Doppler, delivery should be induced with continuous intrapartum fetal monitoring rather than proceeding directly to cesarean section. 1

Delivery Timing and Rationale

  • Delivery at 38-39 weeks is recommended for FGR when the estimated fetal weight is between the 3rd and 10th percentile and the umbilical artery Doppler is normal. 1

  • This patient is already at 38 weeks with normal umbilical artery Doppler (S/D ratio 2.11 is within normal limits), normal amniotic fluid (AFI 8.23 cm), and meets criteria for immediate delivery. 1, 2

  • The ductus arteriosus S/D ratio of 2.11 should not guide clinical management, as middle cerebral artery, ductus venosus, and uterine artery Doppler are not recommended for routine clinical management of late-onset FGR. 1, 2

Mode of Delivery Decision Algorithm

When umbilical artery Doppler is normal:

  • Induction of labor with continuous intrapartum fetal monitoring is appropriate because the fetus has not demonstrated the severe placental insufficiency that would mandate cesarean delivery. 1, 2

  • Normal umbilical artery Doppler indicates that antenatal surveillance complications are unlikely, and problems that do occur are typically intrapartum rather than antepartum. 3

  • Cesarean delivery should be reserved for standard obstetric indications (e.g., failed induction, non-reassuring fetal heart rate during labor). 1

When umbilical artery Doppler shows absent or reversed end-diastolic flow:

  • Cesarean delivery should be strongly considered because 75-95% of FGR pregnancies with absent/reversed end-diastolic velocity require emergency cesarean for intrapartum heart rate abnormalities. 2, 4

  • Absent end-diastolic velocity indicates obliteration of approximately 70% of placental tertiary villi arteries, representing severe placental insufficiency that cannot tolerate labor contractions. 4, 5

  • At 38 weeks with absent end-diastolic flow, the patient is already 4-5 weeks beyond the recommended delivery window of 33-34 weeks, making this a critical scenario requiring urgent cesarean delivery. 1, 2, 4

Intrapartum Monitoring Requirements

  • Continuous electronic fetal monitoring is mandatory throughout labor for any FGR fetus, even with normal Doppler, due to increased risk of intrapartum compromise. 2

  • FGR fetuses with normal Doppler can still develop fetal distress during labor (8.6% incidence), though this is significantly lower than those with abnormal Doppler (26.3%). 3

  • Be prepared for urgent cesarean delivery if non-reassuring fetal heart rate patterns develop during labor. 2

Critical Distinction Based on Doppler Findings

Umbilical Artery Doppler Finding Recommended Mode of Delivery Rationale
Normal diastolic flow (this patient) Induction with continuous monitoring [1,2] Fetus can tolerate labor; complications are intrapartum, not antepartum [3]
Decreased diastolic flow (elevated S/D ratio >95th percentile) Delivery at 37 weeks; consider induction vs cesarean based on clinical scenario [1] Intermediate risk; individualize based on other factors
Absent end-diastolic velocity Cesarean delivery strongly recommended [1,2,4] 75-95% require emergency cesarean for intrapartum decelerations [2]
Reversed end-diastolic velocity Emergency cesarean delivery [1,2,4] Critical placental dysfunction; cannot tolerate labor [4]

Common Pitfalls to Avoid

  • Do not perform cesarean delivery solely based on the FGR diagnosis when umbilical artery Doppler is normal at term, as this unnecessarily increases maternal morbidity without improving neonatal outcomes. 1, 3

  • Do not use ductus arteriosus, middle cerebral artery, or uterine artery Doppler to guide delivery decisions, as these are not recommended for routine clinical management of FGR. 1, 2

  • Do not delay delivery beyond 38-39 weeks even with normal Doppler, as stillbirth risk increases significantly after 38 weeks in growth-restricted fetuses. 1

  • Do not discharge without delivery planning at 38 weeks with documented FGR, as the patient has reached the recommended delivery threshold. 1, 2

Neonatal Preparation

  • Coordinate with neonatology for delivery room attendance, as FGR infants are at increased risk for respiratory distress, hypoglycemia, and temperature instability even at term. 2, 4

  • Obtain cord arterial and venous pH at delivery to objectively assess fetal acid-base status. 4

  • Send placenta for histopathologic examination to guide counseling for future pregnancies. 4

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Guideline

Timing of Delivery for Fetal Growth Restriction (FGR) with Abnormal Dopplers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4
Guideline

Management of Fetal Growth Restriction with Absent End-Diastolic Flow at 37 Weeks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

5
Guideline

Fetal Growth Restriction and Absent End-Diastolic Flow Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the typical time interval between absent diastolic flow and reversed end-diastolic flow in the umbilical artery (UA) of a growth-restricted fetus?
In a pregnant patient with suspected intrauterine growth restriction, how do symmetric (proportionate) and asymmetric (head‑sparing) IUGR differ in timing, etiology, ultrasound and Doppler findings, and clinical management?
For a 38‑week pregnant woman with severe asymmetric fetal growth restriction (abdominal circumference ~2.3th percentile, estimated fetal weight ~20th percentile) who wants a home birth and to wait for spontaneous labor, how often should ultrasound monitoring (biometry and umbilical‑artery Doppler) be performed?
What are the different Doppler (Doppler ultrasound) abnormalities in fetal growth restriction (FGR)?
What is the recommended daily fluid restriction for patients with chronic heart failure, especially those with persistent congestion, hyponatremia, or frequent hospitalizations for volume overload?
In a patient with normal renal function and no contraindications to vancomycin, which is safer for treating serious Gram‑positive infections such as MRSA: linezolid or vancomycin?
How should I manage worsening depression in a patient on high-dose or prolonged corticosteroid therapy?
What is medication‑overuse headache (MOH)?
What are the recommended pharmacologic agents for treating peripheral arterial disease, including first‑line therapy and options for intermittent claudication?
In a patient with methicillin‑resistant Staphylococcus aureus (MRSA) infection, which is more effective, linezolid or vancomycin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question